A new study finds GLP-1 weight loss drugs remain a leading cause of rising health insurance costs in Massachusetts.
Recap by typeshit. Video by NBC10 Boston on TikTok.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Crypto payments to Chinese vendors selling both peptides and fentanyl ingredients rose 32% to $37.3M in 2025, TRM says, with US buyers the largest identifiable source.
Dr Palter shares new research he calls the biggest look yet at GLP-1 medicines in pregnancy, and says the results suggest risks are low.
Loading…